Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma

Ako Hosono, Umio Yamaguchi, Atsushi Makimoto, Makoto Endo, Atsuko Watanabe, Tadakazu Shimoda, Mitsunori Kaya, Tadaki Matsumura, Hiroshi Sonobe, Tomomi Kusumi, Takehiko Yamaguchi, Tadashi Hasegawa

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Aims: To study the immunoexpression of cyclo-oxygenase (COX) 2 in osteoblastomas (OBs) and osteosarcomas (OSs), and to assess the utility of immunohistochemical analysis for COX 2 in the differential diagnosis of the two tumour forms. Methods: The immunohistochemical features of COX 2 were studied in 11 OBs and 30 OSs, including 26 high-grade OSs (16 osteoblastic, 7 chondroblastic, and 3 fibroblastic) and 4 low-grade OSs. Results: Tumour cells from all 11 OBs unequivocally showed diffuse, intense and cytoplasmic immunoreactivity for COX 2. Strong cytoplasmic expression of COX 2 was observed in 5 of 26 (19%) high-grade OSs, all chondroblastic. In one osteoblastic-type OS, COX 2 was expressed in the chondroblastic component, but this tumour was considered to be COX 2 negative. No COX 2 expression was noted in atypical osteoblastic cells. Staining in the four low-grade OSs was negative. Conclusion: The results of immunohistochemical analysis of COX 2 suggest that in addition to the routine histopathological evaluation, COX 2 is a valuable diagnostic marker in the distinction between OB and OS.

Original languageEnglish
Pages (from-to)410-414
Number of pages5
JournalJournal of Clinical Pathology
Volume60
Issue number4
DOIs
Publication statusPublished - Apr 1 2007

Fingerprint

Osteoblastoma
Osteosarcoma
Prostaglandin-Endoperoxide Synthases
Differential Diagnosis
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma. / Hosono, Ako; Yamaguchi, Umio; Makimoto, Atsushi; Endo, Makoto; Watanabe, Atsuko; Shimoda, Tadakazu; Kaya, Mitsunori; Matsumura, Tadaki; Sonobe, Hiroshi; Kusumi, Tomomi; Yamaguchi, Takehiko; Hasegawa, Tadashi.

In: Journal of Clinical Pathology, Vol. 60, No. 4, 01.04.2007, p. 410-414.

Research output: Contribution to journalArticle

Hosono, A, Yamaguchi, U, Makimoto, A, Endo, M, Watanabe, A, Shimoda, T, Kaya, M, Matsumura, T, Sonobe, H, Kusumi, T, Yamaguchi, T & Hasegawa, T 2007, 'Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma', Journal of Clinical Pathology, vol. 60, no. 4, pp. 410-414. https://doi.org/10.1136/jcp.2006.038828
Hosono, Ako ; Yamaguchi, Umio ; Makimoto, Atsushi ; Endo, Makoto ; Watanabe, Atsuko ; Shimoda, Tadakazu ; Kaya, Mitsunori ; Matsumura, Tadaki ; Sonobe, Hiroshi ; Kusumi, Tomomi ; Yamaguchi, Takehiko ; Hasegawa, Tadashi. / Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma. In: Journal of Clinical Pathology. 2007 ; Vol. 60, No. 4. pp. 410-414.
@article{d03d7a1ce0e34e4586d30de64525964a,
title = "Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma",
abstract = "Aims: To study the immunoexpression of cyclo-oxygenase (COX) 2 in osteoblastomas (OBs) and osteosarcomas (OSs), and to assess the utility of immunohistochemical analysis for COX 2 in the differential diagnosis of the two tumour forms. Methods: The immunohistochemical features of COX 2 were studied in 11 OBs and 30 OSs, including 26 high-grade OSs (16 osteoblastic, 7 chondroblastic, and 3 fibroblastic) and 4 low-grade OSs. Results: Tumour cells from all 11 OBs unequivocally showed diffuse, intense and cytoplasmic immunoreactivity for COX 2. Strong cytoplasmic expression of COX 2 was observed in 5 of 26 (19{\%}) high-grade OSs, all chondroblastic. In one osteoblastic-type OS, COX 2 was expressed in the chondroblastic component, but this tumour was considered to be COX 2 negative. No COX 2 expression was noted in atypical osteoblastic cells. Staining in the four low-grade OSs was negative. Conclusion: The results of immunohistochemical analysis of COX 2 suggest that in addition to the routine histopathological evaluation, COX 2 is a valuable diagnostic marker in the distinction between OB and OS.",
author = "Ako Hosono and Umio Yamaguchi and Atsushi Makimoto and Makoto Endo and Atsuko Watanabe and Tadakazu Shimoda and Mitsunori Kaya and Tadaki Matsumura and Hiroshi Sonobe and Tomomi Kusumi and Takehiko Yamaguchi and Tadashi Hasegawa",
year = "2007",
month = "4",
day = "1",
doi = "10.1136/jcp.2006.038828",
language = "English",
volume = "60",
pages = "410--414",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma

AU - Hosono, Ako

AU - Yamaguchi, Umio

AU - Makimoto, Atsushi

AU - Endo, Makoto

AU - Watanabe, Atsuko

AU - Shimoda, Tadakazu

AU - Kaya, Mitsunori

AU - Matsumura, Tadaki

AU - Sonobe, Hiroshi

AU - Kusumi, Tomomi

AU - Yamaguchi, Takehiko

AU - Hasegawa, Tadashi

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Aims: To study the immunoexpression of cyclo-oxygenase (COX) 2 in osteoblastomas (OBs) and osteosarcomas (OSs), and to assess the utility of immunohistochemical analysis for COX 2 in the differential diagnosis of the two tumour forms. Methods: The immunohistochemical features of COX 2 were studied in 11 OBs and 30 OSs, including 26 high-grade OSs (16 osteoblastic, 7 chondroblastic, and 3 fibroblastic) and 4 low-grade OSs. Results: Tumour cells from all 11 OBs unequivocally showed diffuse, intense and cytoplasmic immunoreactivity for COX 2. Strong cytoplasmic expression of COX 2 was observed in 5 of 26 (19%) high-grade OSs, all chondroblastic. In one osteoblastic-type OS, COX 2 was expressed in the chondroblastic component, but this tumour was considered to be COX 2 negative. No COX 2 expression was noted in atypical osteoblastic cells. Staining in the four low-grade OSs was negative. Conclusion: The results of immunohistochemical analysis of COX 2 suggest that in addition to the routine histopathological evaluation, COX 2 is a valuable diagnostic marker in the distinction between OB and OS.

AB - Aims: To study the immunoexpression of cyclo-oxygenase (COX) 2 in osteoblastomas (OBs) and osteosarcomas (OSs), and to assess the utility of immunohistochemical analysis for COX 2 in the differential diagnosis of the two tumour forms. Methods: The immunohistochemical features of COX 2 were studied in 11 OBs and 30 OSs, including 26 high-grade OSs (16 osteoblastic, 7 chondroblastic, and 3 fibroblastic) and 4 low-grade OSs. Results: Tumour cells from all 11 OBs unequivocally showed diffuse, intense and cytoplasmic immunoreactivity for COX 2. Strong cytoplasmic expression of COX 2 was observed in 5 of 26 (19%) high-grade OSs, all chondroblastic. In one osteoblastic-type OS, COX 2 was expressed in the chondroblastic component, but this tumour was considered to be COX 2 negative. No COX 2 expression was noted in atypical osteoblastic cells. Staining in the four low-grade OSs was negative. Conclusion: The results of immunohistochemical analysis of COX 2 suggest that in addition to the routine histopathological evaluation, COX 2 is a valuable diagnostic marker in the distinction between OB and OS.

UR - http://www.scopus.com/inward/record.url?scp=34247148024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247148024&partnerID=8YFLogxK

U2 - 10.1136/jcp.2006.038828

DO - 10.1136/jcp.2006.038828

M3 - Article

C2 - 16822878

AN - SCOPUS:34247148024

VL - 60

SP - 410

EP - 414

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

IS - 4

ER -